Corbus Pharmaceuticals News

Corbus Pharmaceuticals Analyst Ratings

BenzingaJun 3 07:22

Oppenheimer Maintains Outperform on Corbus Pharmaceuticals, Raises Price Target to $80

BenzingaJun 3 07:23

Analysts' Top Healthcare Picks: Praxis Precision Medicines (PRAX), Corbus Pharmaceuticals (CRBP)

TipRanksMay 20 05:32

Corbus Pharmaceuticals (CRBP.US) was first covered by the Royal Bank of Canada, which gave it an superior market rating, with a target price of $77.00.

Zhitong FinanceMay 13 06:32

Corbus Pharmaceuticals Analyst Ratings

BenzingaMay 13 06:23

RBC Capital Initiates Coverage On Corbus Pharmaceuticals With Outperform Rating, Announces Price Target of $77

BenzingaMay 13 06:24

Corbus Pharmaceuticals Analyst Ratings

BenzingaMay 8 10:53

Oppenheimer Maintains Outperform on Corbus Pharmaceuticals, Raises Price Target to $60

BenzingaMay 8 10:54

Corbus Pharmaceuticals Analyst Ratings

BenzingaMar 13 07:31

Corbus Pharmaceuticals Analyst Ratings

BenzingaMar 6 07:16

Jefferies Upgrades Corbus Pharmaceuticals to Buy, Raises Price Target to $46

BenzingaMar 6 07:18

Corbus Pharmaceuticals Analyst Ratings

BenzingaJan 29 12:39

Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $51 From $20, Maintains Outperform Rating

MT NewswiresJan 29 08:14

Analysts Are Bullish on Top Healthcare Stocks: Biogen (BIIB), Corbus Pharmaceuticals (CRBP)

TipRanksJan 29 07:12

Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $20 From $22, Maintains Outperform Rating

MT NewswiresNov 8, 2023 08:12

Oppenheimer Reiterates Outperform on Corbus Pharmaceuticals, Maintains $22 Price Target

BenzingaAug 9, 2023 08:47

Corbus Pharmaceuticals Analyst Ratings

BenzingaAug 9, 2023 08:46

Oppenheimer Upgrades Corbus Pharmaceuticals to Outperform, Announces $22 Price Target

BenzingaMay 10, 2023 07:36

H.C. Wainwright Sticks to Its Buy Rating for Corbus Pharmaceuticals (CRBP)

TipRanksMar 8, 2023 06:32

HC Wainwright & Co. Reiterates Buy on Corbus Pharmaceuticals, Maintains $3 Price Target

BenzingaMar 8, 2023 05:16